Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration

BACKGROUND: The metabolomic and proteomic basis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is poorly understood and the relationships between systemic abnormalities in metabolism and AD/AMCI pathogenesis are unclear. OBJECTIVE: The aim of the study was to compare the metabolomic...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Maxime, Karpe, Avinash, Liu, Jian-Wei, Beale, David, Hor, Maryam, Hecker, Jane, Faunt, Jeff, Maddison, John, Johns, Sally, Doecke, James, Rose, Stephen, Leifert, Wayne R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461673/
https://www.ncbi.nlm.nih.gov/pubmed/34151801
http://dx.doi.org/10.3233/JAD-210283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461673/
https://www.ncbi.nlm.nih.gov/pubmed/34151801
http://dx.doi.org/10.3233/JAD-210283

Ejemplares similares